[1]
|
Kocijancic, D., Felgner, S., Frahm, M., et al. (2016) Therapy of Solid Tumors Using Probiotic Symbioflor-2—Restraints and Potential. Oncotarget, 7, 22605-22622. https://doi.org/10.18632/oncotarget.8027
|
[2]
|
HoptionCann, S.A., Van Netten, J.P. and Van Netten, C. (2003) Dr William Coley and Tumour Regression: A Place in History or in the Future. Postgraduate Medical Journal, 79, 672-680. https://doi.org/10.1093/postgradmedj/79.938.672
|
[3]
|
Choi, Y., Lichterman, J.N., Coughlin, L.A., et al. (2023) Immune Checkpoint Blockade Induces Gut Microbiota Translocation That Augments Extraintestinal Antitumor Immunity. Science Immunology, 8, Eabo2003. https://doi.org/10.1126/sciimmunol.abo2003
|
[4]
|
Bender, M.J., McPherson, A.C., Phelps, C.M., et al. (2023) Dietary Tryptophan Metabolite Released by Intratumoral Lactobacillus reuteri Facilitates Immune Checkpoint Inhibitor Treatment. Cell, 186, 1846-1862.E26. https://doi.org/10.1016/j.cell.2023.03.011
|
[5]
|
Galeano Niño, J.L., Wu, H., LaCourse, K.D., et al. (2022) Effect of the Intratumoral Microbiota on Spatial and Cellular Heterogeneity in Cancer. Nature, 611, 810-817. https://doi.org/10.1038/s41586-022-05435-0
|
[6]
|
Fu, A., Yao, B., Dong, T., et al. (2022) Tumor-Resident Intracellular Microbiota Promotes Metastatic Colonization in Breast Cancer. Cell, 185, 1356-1372.E26. https://doi.org/10.1016/j.cell.2022.02.027
|
[7]
|
Nolan, E., Bridgeman, V.L., Ombrato, L., et al. (2022) Radiation Exposure Elicits a Neutrophil-Driven Response in Healthy Lung Tissue That Enhances Metastatic Colonization. Nature Cancer, 3, 173-187. https://doi.org/10.1038/s43018-022-00336-7
|
[8]
|
Zheng, J.H., Nguyen, V.H., Jiang, S.-N., et al. (2017) Two-Step Enhanced Cancer Immunotherapy with Engineered Salmonella typhimurium Secreting Heterologous Flagellin. Science Translational Medicine, 9, Eaak9537. https://doi.org/10.1126/scitranslmed.aak9537
|
[9]
|
Forbes, N.S., Munn, L.L., Fukumura, D., et al. (2003) Sparse Initial Entrapment of Systemically Injected Salmonella typhimurium Leads to Heterogeneous Accumulation within Tumors. Cancer Research, 63, 5188-5193.
|
[10]
|
Tang, Q., Peng, X., Xu, B., et al. (2022) Current Status and Future Directions of Bacteria-Based Immunotherapy. Frontiers in Immunology, 13, Article ID: 911783. https://doi.org/10.3389/fimmu.2022.911783
|
[11]
|
Leventhal, D.S., Sokolovska, A., Li, N., et al. (2020) Immunotherapy with Engineered Bacteria by Targeting the STING Pathway for Anti-Tumor Immunity. Nature Communications, 11, Article No. 2739. https://doi.org/10.1038/s41467-020-16602-0
|
[12]
|
Fang, R., Jiang, Q., Jia, X., et al. (2023) ARMH3-Mediated Recruitment of PI4KB Directs Golgi-to-Endosome Trafficking and Activation of the Antiviral Effector STING. Immunity, 56, 500-515.E6. https://doi.org/10.1016/j.immuni.2023.02.004
|
[13]
|
Zhang, X., Bai, X.-C. and Chen, Z.J. (2020) Structures and Mechanisms in the CGAS-STING Innate Immunity Pathway. Immunity, 53, 43-53. https://doi.org/10.1016/j.immuni.2020.05.013
|
[14]
|
Yu, X., Lin, C., Yu, J., et al. (2019) Bioengineered Escherichia coli Nissle 1917 for Tumour-Targeting Therapy. Microbial Biotechnology, 13, 629-636. https://doi.org/10.1111/1751-7915.13523
|
[15]
|
Behnsen, J., Deriu, E., Sassone-Corsi, M., et al. (2013) Probiotics: Properties, Examples, and Specific Applications. Cold Spring Harbor Perspectives in Medicine, 3, A010074. https://doi.org/10.1101/cshperspect.a010074
|
[16]
|
Reister, M., Hoffmeier, K., Krezdorn, N., et al. (2014) Complete Genome Sequence of the Gram-Negative Probiotic Escherichia coli Strain Nissle 1917. Journal of Biotechnology, 187, 106-107. https://doi.org/10.1016/j.jbiotec.2014.07.442
|
[17]
|
Clairmont, C., Lee, K.C., Pike, J., et al. (2000) Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain of Salmonella typhimurium. The Journal of Infectious Diseases, 181, 1996-2002. https://doi.org/10.1086/315497
|
[18]
|
Toso, J.F., Gill, V.J., Hwu, P., et al. (2002) Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients with Metastatic Melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 20, 142-152. https://doi.org/10.1200/JCO.2002.20.1.142
|
[19]
|
Zhou, D.-X., Wang, X.-H., Xu, X., et al. (2022) Anti-Tumor Effects of Engineered VNP20009-Abvec-Igκ-MPD-1 Strain in Melanoma Mice via Combining the Oncolytic Therapy and Immunotherapy. Pharmaceutics, 14, Article No. 2789. https://doi.org/10.3390/pharmaceutics14122789
|
[20]
|
Pawelek, J.M., Low, K.B. and Bermudes, D. (1997) Tumor-Targeted Salmonella as a Novel Anticancer Vector. Cancer Research, 57, 4537-4544.
|
[21]
|
Garza-Morales, R., Rendon, B.E., Malik, M.T., et al. (2020) Targeting Melanoma Hypoxia with the Food-Grade Lactic Acid Bacterium Lactococcus lactis. Cancers, 12, Article No. 438. https://doi.org/10.3390/cancers12020438
|
[22]
|
Feizollahzadeh, S., Khanahmad, H., Rahimmanesh, I., et al. (2016) Expression of Biologically Active Murine Interleukin-18 in Lactococcus lactis. FEMS Microbiology Letters, 363, Fnw234. https://doi.org/10.1093/femsle/fnw234
|
[23]
|
Zhu, J., Ke, Y., Liu, Q., et al. (2022) Engineered Lactococcus lactis Secreting Flt3L and OX40 Ligand for in Situ Vaccination-Based Cancer Immunotherapy. Nature Communications, 13, Article No. 7466. https://doi.org/10.1038/s41467-022-35130-7
|
[24]
|
Zhang, H.-Y., Man, J.-H., Liang, B., et al. (2010) Tumor-Targeted Delivery of Biologically Active TRAIL Protein. Cancer Gene Therapy, 17, 334-343. https://doi.org/10.1038/cgt.2009.76
|
[25]
|
Malla, W.A., Arora, R., Khan, R.I.N., et al. (2020) Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems. Frontiers in Cell and Developmental Biology, 8, Article No. 524. https://doi.org/10.3389/fcell.2020.00524
|
[26]
|
Guan, G., Zhao, M., Liu, L., et al. (2013) Salmonella typhimurium Mediated Delivery of Apoptin in Human Laryngeal Cancer. International Journal of Medical Sciences, 10, 1639-1648. https://doi.org/10.7150/ijms.6960
|
[27]
|
Zhang, Y.-L., Lü, R., Chang, Z.-S., et al. (2014) Clostridium Sporogenes Delivers Interleukin-12 to Hypoxic Tumours, Producing Antitumour Activity without Significant Toxicity. Letters in Applied Microbiology, 59, 580-586. https://doi.org/10.1111/lam.12322
|
[28]
|
Loeffler, M., Le’Negrate, G., Krajewska, M., et al. (2007) Attenuated Salmonella Engineered to Produce Human Cytokine LIGHT Inhibit Tumor Growth. Proceedings of the National Academy of Sciences of the United States of America, 104, 12879-12883. https://doi.org/10.1073/pnas.0701959104
|
[29]
|
Savage, T.M., Vincent, R.L., Rae, S.S., et al. (2023) Chemokines Expressed by Engineered Bacteria Recruit and Orchestrate Antitumor Immunity. Science Advances, 9, Eadc9436. https://doi.org/10.1126/sciadv.adc9436
|
[30]
|
Namai, F., Murakami, A., Ueda, A., et al. (2020) Construction of Genetically Modified Lactococcus lactis Producing Anti-Human-CTLA-4 Single-Chain Fragment Variable. Molecular Biotechnology, 62, 572-579. https://doi.org/10.1007/s12033-020-00274-8
|
[31]
|
Gurbatri, C.R., Lia, I., Vincent, R., et al. (2020) Engineered Probiotics for Local Tumor Delivery of Checkpoint Blockade Nanobodies. Science Translational Medicine, 12, Eaax0876. https://doi.org/10.1126/scitranslmed.aax0876
|
[32]
|
Vincent, R.L., Gurbatri, C.R., Li, F., et al. (2023) Probiotic-Guided CAR-T Cells for Solid Tumor Targeting. Science, 382, 211-218. https://doi.org/10.1126/science.add7034
|
[33]
|
Song, P., Han, X., Li, X., et al. (2023) Bacteria Engineered with Intracellular and Extracellular Nanomaterials for Hierarchical Modulation of Antitumor Immune Responses. Materials Horizons, 10, 2927-2935. https://doi.org/10.1039/D3MH00249G
|
[34]
|
Wu, W., Pu, Y., Gao, S., et al. (2022) Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy. Nano-Micro Letters, 14, Article No. 220. https://doi.org/10.1007/s40820-022-00951-0
|
[35]
|
Ma, X., Liang, X., Li, Y., et al. (2023) Modular-Designed Engineered Bacteria for Precision Tumor Immunotherapy via Spatiotemporal Manipulation by Magnetic Field. Nature Communications, 14, Article No. 1606. https://doi.org/10.1038/s41467-023-37225-1
|